title: Re: Vartanian T. An examination of the results of the EVIDENCE, INCOMIN, and phase III studies of interferon beta products in the treatment of multiple sclerosis. Clin Ther. 2003;25:105-118.
authors.forename: Grodon
authors.initials: G
authors.lastname: Francis
authors.forename: Hillel
authors.initials: H
authors.lastname: Panitich
authors.forename: Brian
authors.initials: B
authors.lastname: Weinshenker
authors.forename: Ed
authors.initials: E
authors.lastname: Monaghan
authors.forename: Paul
authors.initials: P
authors.lastname: O'Connor
mesh_terms: D017326:Clinical Trials, Phase III as Topic; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging / Q000379:methods; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D016899:Interferon-beta; D000068556:Interferon beta-1a